Summary

1. How They Found Us – LinkedIn outreach

2. Local Prevalence – 5.8M official diagnoses; 270K devices government procurement

3. Partnership Model – Model 2 (Core Components)

4. Visual Assets – CGM PCBA product images & Moscow facility photos (available upon request)

5. Key Results – First batch completed in 10 months; Roszdravnadzor registration filed

The client, a Top 10 medical device distributor in Russia, connected with XingDa through LinkedIn outreach by our business development team.

Russia has 5.8 million officially diagnosed diabetes patients, with experts estimating up to 12 million. The government allocated 5 billion RUB (≈USD 55M) for CGM procurement – approximately 270,000 devices. The introduction of GOST R 72213-2025, Russia‘s first national CGM standard, created a clear regulatory framework.

XingDa delivered Model 2 – Core Components Supply:

Results: CGM production established in Moscow. First batch completed within 10 months. Roszdravnadzor registration filed. Client positioned for government CGM procurement program.

“XingDa gave us a complete CGM manufacturing ecosystem – from PCBA to production line setup to regulatory guidance.”
– CEO, Russian Medical Device Company

Partnership Models – Quick Reference

Contact Us

📧 Email: sales@xdpcba.com | Bluesky@xdpcba.com | sales15@xdpcba.com
🌐 Website: www.xdpcba.com
📱 Phone/WeChat/WhatsApp: +86 15919476409